Skip to main content

Drug Overdose

Description

Drug overdoses are now the leading cause of accidental death in the United States, with an estimated 60,000 deaths in 2016. Nationally, EMS overdose responses with naloxone administration have nearly doubled from 2012 to 2016 from 573.6 to 1004.4 per 100,000 EMS events. Resuscitation using the opioid antagonist, naloxone is recommended in cases of suspected opioid ODs, and has been increasingly used by EMS agencies, law enforcement, healthcare providers, and Good Samaritans. While naloxone can save lives, it is not clear how often its use is appropriate; delivering the right care to the right patient at the right time. It has been suggested that community paramedic programs teamed with recovery services may help link OD patients to recovery and rehabilitation services and establish mechanisms for follow-up care. Prior to implementing community EMS programs, it is important to understand the EMS utilization patterns of the OD population. I-EMS interactions may present an opportunity for behavioral intervention and linkage to services to prevent future OD and death in the opioid-using population. Accurately documenting substances involved in drug overdose deaths has been of increasing interest to Marion County and Indiana with a recent law requiring toxicology testing 5,6. This project linked individual-level data across public health information systems to assess the appropriateness of naloxone administration, the frequency of I-EMS service utilization until final death outcome among the I-EMS OD deceased cohort, and underlying causes of death among the cohort.

Objective: To characterize the appropriateness of naloxone administration, causes of death, and history of Indianapolis Emergency Medical Services (I-EMS) service utilization among the drug overdose population in Marion County, Indiana between 2011 to 2017.

Submitted by elamb on
Description

In North Carolina there has been an escalation of poisoning deaths. In 2011, the number of fatal poisonings was 1,368 deaths, with 91% classified as drug overdoses with the majority of those due to opioid analgesics.[1] Far greater numbers of drug overdoses result in hospitalization, emergency department (ED) or outpatient clinic visits, or resolve without the individual seeking medical attention. Although public health authorities have long employed death data for drug overdose surveillance in NC, little attention has been paid to the use of ED data for this purpose. Through the North Carolina Disease Event Tracking and Epidemiologic Collection Tool (NC DETECT), NC collects information on 99.5% of all acute-care ED visits across the state, primarily for syndromic surveillance purposes. Despite the timeliness and completeness of this data system, drug overdose surveillance is a challenge due to lack of a standardized definition for the positive identification of opioid overdoses. In this study we used NC DETECT ED data to describe visits due to drug, and more specifically, opioid overdoses. Objective: To describe the epidemiologic characteristics for emergency department visits due to drug overdoses in North Carolina.

Submitted by elamb on
Description

During March-May 2013, 14 overdose deaths occurred in RI that were caused by acetyl fentanyl, a novel synthetic opioid about five times more potent than heroin1. Ten of these deaths were clustered in March, causing a significant increase over baseline of monthly illicit drug overdose deaths in RI1. Overdose deaths are well described in RI by forensic toxicology testing results. However, the overall number of ED visits associated with this event was unknown. We used RODS data retrospectively to characterize overdose related ED visits in RI and to analyze trends.

Objective

Determine if the Rhode Island (RI) Real-time Outbreak and Disease Surveillance (RODS) system (a syndromic surveillance system) identified an increase in overdoses during a known cluster of illicit drug overdose deaths in RI and characterize emergency department (ED) overdose visits during the 15 month period prior to and including the known cluster.

Submitted by elamb on

These slides were presented at the Enhanced State Opioid Overdose Surveillance (ESOOS) Program Overview Partner meeting, led by CDC and organized by ASTHO in March of 2019. 

Presenters

Puja Seth, PhD – Lead, Epidemiology and Surveillance

Alana Vivolo-Kantor, PhD – Morbidity Lead

Christine L. Mattson, PhD – Mortality Lead

Objectives

Submitted by uysz on

Louisiana, like other states, grapples with widespread drug abuse. CDC’s DrugOverdose Death Data show Louisiana had a statistically significant 14.7% increase in its drug overdose death rate from 2015–2016. As early as 2013, the Louisiana Office of Public Health, Infectious Disease Epidemiology section (IDEpi), began receiving requests for drug abuse data from the governor’s office and community- based organizations for a deeper understanding of overdose trends and populations at greatest risk.

Submitted by elamb on

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC ALL DRUG V2 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

Submitted by Anonymous on

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC OPIOID V3 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

Submitted by Anonymous on

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC HEROIN OVERDOSE V4 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

Submitted by Anonymous on

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC STIMULANT OVERDOSE V3 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

Submitted by Anonymous on